Another study revealed that HIF1A-As2 epigenetically activates MYC by attracting DHX9 to the MYC promoter, thereby promoting the transcription of MYC and its target genes in KRAS-driven non-small cell lung cancer 49. Here, DHX9 is linked to non-small cell lung carcinoma.